BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11189689)

  • 1. Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
    Stallings FL; Ford ME; Simpson NK; Fouad M; Jernigan JC; Trauth JM; Miller DS;
    Control Clin Trials; 2000 Dec; 21(6 Suppl):379S-389S. PubMed ID: 11189689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting older african american women's decisions to join the PLCO Cancer Screening Trial.
    Trauth JM; Jernigan JC; Siminoff LA; Musa D; Neal-Ferguson D; Weissfeld J
    J Clin Oncol; 2005 Dec; 23(34):8730-8. PubMed ID: 16314633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.
    Gohagan JK; Prorok PC; Hayes RB; Kramer BS;
    Control Clin Trials; 2000 Dec; 21(6 Suppl):251S-272S. PubMed ID: 11189683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrollment of racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Pinsky PF; Ford M; Gamito E; Higgins D; Jenkins V; Lamerato L; Tenorio S; Marcus PM; Gohagan JK
    J Natl Med Assoc; 2008 Mar; 100(3):291-8. PubMed ID: 18390022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recruitment strategies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: the first six years.
    Simpson NK; Johnson CC; Ogden SL; Gamito E; Trocky N; McGuire C; Martin J; Barrow S; Lamerato L; Flickinger LM; Broski KG; Engelhard D; Hilke C; Bonk J; Gahagan B; Gren LH; Childs J; Lappe K; Fouad M; Thompson J; Sullivan D;
    Control Clin Trials; 2000 Dec; 21(6 Suppl):356S-378S. PubMed ID: 11189688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing Multi-Center Recruitment in the PLCO Cancer Screening Trial.
    Gohagan JK; Broski K; Gren LH; Fouad MN; Higgins D; Lappe K; Ogden S; Shambaugh V; Pinsky PF; O'Brien B; Yurgalevich S; Riley T; Wright P; Prorok PC
    Rev Recent Clin Trials; 2015; 10(3):187-93. PubMed ID: 26435288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of recruitment methods for older African American men in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
    Ford ME; Havstad SL; Davis SD
    Clin Trials; 2004; 1(4):343-51. PubMed ID: 16279272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
    Miller AB; Yurgalevitch S; Weissfeld JL;
    Control Clin Trials; 2000 Dec; 21(6 Suppl):400S-406S. PubMed ID: 11189691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality control of cancer screening examination procedures in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
    Weissfeld JL; Fagerstrom RM; O'Brien B;
    Control Clin Trials; 2000 Dec; 21(6 Suppl):390S-399S. PubMed ID: 11189690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordination and management of a large multicenter screening trial: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
    O'Brien B; Nichaman L; Browne JE; Levin DL; Prorok PC; Gohagan JK;
    Control Clin Trials; 2000 Dec; 21(6 Suppl):310S-328S. PubMed ID: 11189685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Andriole GL
    Recent Results Cancer Res; 2014; 202():53-7. PubMed ID: 24531777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
    Prorok PC; Andriole GL; Bresalier RS; Buys SS; Chia D; Crawford ED; Fogel R; Gelmann EP; Gilbert F; Hasson MA; Hayes RB; Johnson CC; Mandel JS; Oberman A; O'Brien B; Oken MM; Rafla S; Reding D; Rutt W; Weissfeld JL; Yokochi L; Gohagan JK;
    Control Clin Trials; 2000 Dec; 21(6 Suppl):273S-309S. PubMed ID: 11189684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recruitment in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: the first phase of recruitment at Henry Ford Health System.
    Lamerato LE; Marcus PM; Jacobsen G; Johnson CC
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):827-33. PubMed ID: 18398023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Quality Management (CQM) in the PLCO Trial.
    Gohagan JK; O'Brien B; Hasson MA; Umbel KD; Bridgeman B; Kramer BS; Reding D; Gren L; Wright P; Riley T; Prorok PC
    Rev Recent Clin Trials; 2015; 10(3):223-32. PubMed ID: 26238118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results.
    Gohagan JK; Prorok PC; Greenwald P; Kramer BS
    Rev Recent Clin Trials; 2015; 10(3):173-80. PubMed ID: 26238115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort.
    Lacey JV; Kreimer AR; Buys SS; Marcus PM; Chang SC; Leitzmann MF; Hoover RN; Prorok PC; Berg CD; Hartge P;
    BMC Cancer; 2009 Mar; 9():84. PubMed ID: 19292893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and evolution of the data management systems in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
    Hasson MA; Fagerstrom RM; Kahane DC; Walsh JH; Myers MH; Caughman C; Wenzel B; Haralson JC; Flickinger LM; Turner LM;
    Control Clin Trials; 2000 Dec; 21(6 Suppl):329S-348S. PubMed ID: 11189686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recruitment methods employed in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Gren L; Broski K; Childs J; Cordes J; Engelhard D; Gahagan B; Gamito E; Gardner V; Geisser M; Higgins D; Jenkins V; Lamerato L; Lappe K; Lowery H; McGuire C; Miedzinski M; Ogden S; Tenorio S; Watt G; Wohlers B; Marcus P
    Clin Trials; 2009 Feb; 6(1):52-9. PubMed ID: 19254935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A different interpretation of the efficacy of lung cancer screening in the PLCO trial.
    Sagawa M; Nakayama T; Sobue T;
    Eur J Epidemiol; 2016 Feb; 31(2):211-2. PubMed ID: 26197850
    [No Abstract]   [Full Text] [Related]  

  • 20. Building Successful Relationships in the PLCO Cancer Screening Trial.
    Marcus PM; Broski KG; Buys SS; Childs J; Church TR; Gohagan JK; Gren LH; Higgins D; Jaggi R; Jenkins V; Johnson CC; Lappe K; O'Brien B; Ogden SL; Prorok PC; Reding D; Shambaugh V; Yokochi LA; Yurgalevitch S
    Rev Recent Clin Trials; 2015; 10(3):181-6. PubMed ID: 26238208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.